CannaPharmaRX, Inc.
CannaPharmaRX, Inc. CPMD Peers
See (CPMD) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CPMD | $0.00 | +48.48% | 3.25M | 0.49 | $0.01 | N/A |
| MKGAF | $132.58 | +1.59% | 57.64B | 18.21 | $7.28 | +1.72% |
| MKKGY | $26.01 | +0.35% | 56.07B | 17.94 | $1.45 | +1.48% |
| HLNCF | $5.57 | +1.18% | 50.20B | 26.50 | $0.21 | +1.94% |
| TKPHF | $26.30 | N/A | 41.39B | 57.17 | $0.46 | +5.06% |
| IPSEY | $28.88 | -2.83% | 38.22B | 24.27 | $1.19 | +1.08% |
| TEVJF | $19.31 | +19.86% | 22.13B | -16.79 | -$1.15 | N/A |
| SDZNY | $49.30 | +1.65% | 21.23B | -2465.00 | -$0.02 | +0.83% |
| ESALY | $61.51 | -2.11% | 17.64B | 20.54 | $3.00 | N/A |
| SGIOY | $8.12 | -0.37% | 13.82B | 11.77 | $0.69 | +0.87% |
Stock Comparison
CPMD vs MKGAF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, MKGAF has a market cap of 57.64B. Regarding current trading prices, CPMD is priced at $0.00, while MKGAF trades at $132.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas MKGAF's P/E ratio is 18.21. In terms of profitability, CPMD's ROE is +0.52%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, CPMD is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs MKKGY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, MKKGY has a market cap of 56.07B. Regarding current trading prices, CPMD is priced at $0.00, while MKKGY trades at $26.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas MKKGY's P/E ratio is 17.94. In terms of profitability, CPMD's ROE is +0.52%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, CPMD is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs HLNCF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, HLNCF has a market cap of 50.20B. Regarding current trading prices, CPMD is priced at $0.00, while HLNCF trades at $5.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas HLNCF's P/E ratio is 26.50. In terms of profitability, CPMD's ROE is +0.52%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, CPMD is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs TKPHF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, TKPHF has a market cap of 41.39B. Regarding current trading prices, CPMD is priced at $0.00, while TKPHF trades at $26.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas TKPHF's P/E ratio is 57.17. In terms of profitability, CPMD's ROE is +0.52%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, CPMD is less volatile compared to TKPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs IPSEY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, IPSEY has a market cap of 38.22B. Regarding current trading prices, CPMD is priced at $0.00, while IPSEY trades at $28.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas IPSEY's P/E ratio is 24.27. In terms of profitability, CPMD's ROE is +0.52%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, CPMD is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs TEVJF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, TEVJF has a market cap of 22.13B. Regarding current trading prices, CPMD is priced at $0.00, while TEVJF trades at $19.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas TEVJF's P/E ratio is -16.79. In terms of profitability, CPMD's ROE is +0.52%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, CPMD and TEVJF have similar daily volatility (0.00).
CPMD vs SDZNY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, SDZNY has a market cap of 21.23B. Regarding current trading prices, CPMD is priced at $0.00, while SDZNY trades at $49.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas SDZNY's P/E ratio is -2465.00. In terms of profitability, CPMD's ROE is +0.52%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, CPMD is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs ESALY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, ESALY has a market cap of 17.64B. Regarding current trading prices, CPMD is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas ESALY's P/E ratio is 20.54. In terms of profitability, CPMD's ROE is +0.52%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, CPMD is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs SGIOY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, SGIOY has a market cap of 13.82B. Regarding current trading prices, CPMD is priced at $0.00, while SGIOY trades at $8.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas SGIOY's P/E ratio is 11.77. In terms of profitability, CPMD's ROE is +0.52%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, CPMD is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs SGIOF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, SGIOF has a market cap of 12.93B. Regarding current trading prices, CPMD is priced at $0.00, while SGIOF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas SGIOF's P/E ratio is 11.01. In terms of profitability, CPMD's ROE is +0.52%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, CPMD and SGIOF have similar daily volatility (0.00).
CPMD vs BIOVF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, BIOVF has a market cap of 10.40B. Regarding current trading prices, CPMD is priced at $0.00, while BIOVF trades at $30.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas BIOVF's P/E ratio is 25.67. In terms of profitability, CPMD's ROE is +0.52%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, CPMD is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs IPSEF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, IPSEF has a market cap of 10.37B. Regarding current trading prices, CPMD is priced at $0.00, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas IPSEF's P/E ratio is 26.23. In terms of profitability, CPMD's ROE is +0.52%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, CPMD is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs SFOSF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, SFOSF has a market cap of 8.66B. Regarding current trading prices, CPMD is priced at $0.00, while SFOSF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas SFOSF's P/E ratio is 13.13. In terms of profitability, CPMD's ROE is +0.52%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, CPMD is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs ESALF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, ESALF has a market cap of 7.83B. Regarding current trading prices, CPMD is priced at $0.00, while ESALF trades at $27.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas ESALF's P/E ratio is 24.56. In terms of profitability, CPMD's ROE is +0.52%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, CPMD is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs ESAIY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, ESAIY has a market cap of 7.64B. Regarding current trading prices, CPMD is priced at $0.00, while ESAIY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas ESAIY's P/E ratio is 23.93. In terms of profitability, CPMD's ROE is +0.52%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, CPMD is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs GZPHF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, GZPHF has a market cap of 6.29B. Regarding current trading prices, CPMD is priced at $0.00, while GZPHF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, CPMD's ROE is +0.52%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, CPMD and GZPHF have similar daily volatility (0.00).
CPMD vs HKMPY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, HKMPY has a market cap of 6.19B. Regarding current trading prices, CPMD is priced at $0.00, while HKMPY trades at $56.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas HKMPY's P/E ratio is 17.43. In terms of profitability, CPMD's ROE is +0.52%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, CPMD and HKMPY have similar daily volatility (0.00).
CPMD vs HKMPF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, HKMPF has a market cap of 6.11B. Regarding current trading prices, CPMD is priced at $0.00, while HKMPF trades at $27.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas HKMPF's P/E ratio is 17.22. In terms of profitability, CPMD's ROE is +0.52%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, CPMD is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs APNHF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, APNHF has a market cap of 5.44B. Regarding current trading prices, CPMD is priced at $0.00, while APNHF trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas APNHF's P/E ratio is 20.07. In terms of profitability, CPMD's ROE is +0.52%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, CPMD is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs WIBFF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, WIBFF has a market cap of 4.95B. Regarding current trading prices, CPMD is priced at $0.00, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, CPMD's ROE is +0.52%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, CPMD is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs HLBBF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, HLBBF has a market cap of 4.55B. Regarding current trading prices, CPMD is priced at $0.00, while HLBBF trades at $5.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas HLBBF's P/E ratio is 11.96. In terms of profitability, CPMD's ROE is +0.52%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, CPMD is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs LVZPF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, LVZPF has a market cap of 4.01B. Regarding current trading prices, CPMD is priced at $0.00, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, CPMD's ROE is +0.52%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, CPMD is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs HLUBF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, HLUBF has a market cap of 3.55B. Regarding current trading prices, CPMD is priced at $0.00, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas HLUBF's P/E ratio is 7.71. In terms of profitability, CPMD's ROE is +0.52%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, CPMD is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs INVVY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, INVVY has a market cap of 3.01B. Regarding current trading prices, CPMD is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas INVVY's P/E ratio is -62.42. In terms of profitability, CPMD's ROE is +0.52%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, CPMD and INVVY have similar daily volatility (0.00).
CPMD vs APNHY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, APNHY has a market cap of 2.93B. Regarding current trading prices, CPMD is priced at $0.00, while APNHY trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas APNHY's P/E ratio is 11.79. In terms of profitability, CPMD's ROE is +0.52%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, CPMD and APNHY have similar daily volatility (0.00).
CPMD vs IZQVF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, IZQVF has a market cap of 2.89B. Regarding current trading prices, CPMD is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, CPMD's ROE is +0.52%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, CPMD and IZQVF have similar daily volatility (0.00).
CPMD vs HMDCF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, HMDCF has a market cap of 2.79B. Regarding current trading prices, CPMD is priced at $0.00, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, CPMD's ROE is +0.52%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, CPMD is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs HYPMY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, HYPMY has a market cap of 2.61B. Regarding current trading prices, CPMD is priced at $0.00, while HYPMY trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas HYPMY's P/E ratio is 18.77. In terms of profitability, CPMD's ROE is +0.52%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, CPMD is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs DNPUF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, DNPUF has a market cap of 2.59B. Regarding current trading prices, CPMD is priced at $0.00, while DNPUF trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas DNPUF's P/E ratio is 15.93. In terms of profitability, CPMD's ROE is +0.52%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, CPMD is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs ULIHF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, ULIHF has a market cap of 2.54B. Regarding current trading prices, CPMD is priced at $0.00, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, CPMD's ROE is +0.52%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, CPMD is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs THCBF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, THCBF has a market cap of 2.36B. Regarding current trading prices, CPMD is priced at $0.00, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas THCBF's P/E ratio is -0.10. In terms of profitability, CPMD's ROE is +0.52%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, CPMD is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs HTSUF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, HTSUF has a market cap of 2.36B. Regarding current trading prices, CPMD is priced at $0.00, while HTSUF trades at $32.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas HTSUF's P/E ratio is 15.83. In terms of profitability, CPMD's ROE is +0.52%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, CPMD is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs CHSYF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, CHSYF has a market cap of 2.25B. Regarding current trading prices, CPMD is priced at $0.00, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, CPMD's ROE is +0.52%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, CPMD and CHSYF have similar daily volatility (0.00).
CPMD vs TSMRF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, TSMRF has a market cap of 2.13B. Regarding current trading prices, CPMD is priced at $0.00, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, CPMD's ROE is +0.52%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, CPMD and TSMRF have similar daily volatility (0.00).
CPMD vs DMPHF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, DMPHF has a market cap of 2.13B. Regarding current trading prices, CPMD is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas DMPHF's P/E ratio is 18.31. In terms of profitability, CPMD's ROE is +0.52%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, CPMD and DMPHF have similar daily volatility (0.00).
CPMD vs LJUIF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, LJUIF has a market cap of 2.06B. Regarding current trading prices, CPMD is priced at $0.00, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, CPMD's ROE is +0.52%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, CPMD and LJUIF have similar daily volatility (0.00).
CPMD vs LBTSF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, LBTSF has a market cap of 1.92B. Regarding current trading prices, CPMD is priced at $0.00, while LBTSF trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas LBTSF's P/E ratio is 150.17. In terms of profitability, CPMD's ROE is +0.52%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, CPMD is less volatile compared to LBTSF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs CHIZF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, CHIZF has a market cap of 1.69B. Regarding current trading prices, CPMD is priced at $0.00, while CHIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas CHIZF's P/E ratio is 16.80. In terms of profitability, CPMD's ROE is +0.52%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, CPMD and CHIZF have similar daily volatility (0.00).
CPMD vs SHEZF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, SHEZF has a market cap of 1.66B. Regarding current trading prices, CPMD is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, CPMD's ROE is +0.52%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, CPMD is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs SMDPY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, SMDPY has a market cap of 1.63B. Regarding current trading prices, CPMD is priced at $0.00, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas SMDPY's P/E ratio is -1.35. In terms of profitability, CPMD's ROE is +0.52%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, CPMD and SMDPY have similar daily volatility (0.00).
CPMD vs NPPNY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, NPPNY has a market cap of 1.60B. Regarding current trading prices, CPMD is priced at $0.00, while NPPNY trades at $5.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas NPPNY's P/E ratio is 7.17. In terms of profitability, CPMD's ROE is +0.52%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, CPMD is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs NPNKF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, NPNKF has a market cap of 1.59B. Regarding current trading prices, CPMD is priced at $0.00, while NPNKF trades at $23.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas NPNKF's P/E ratio is 7.08. In terms of profitability, CPMD's ROE is +0.52%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, CPMD is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs KARBF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, KARBF has a market cap of 1.52B. Regarding current trading prices, CPMD is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas KARBF's P/E ratio is 262.50. In terms of profitability, CPMD's ROE is +0.52%, compared to KARBF's ROE of N/A. Regarding short-term risk, CPMD and KARBF have similar daily volatility (0.00).
CPMD vs YIHCF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, YIHCF has a market cap of 1.48B. Regarding current trading prices, CPMD is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, CPMD's ROE is +0.52%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, CPMD and YIHCF have similar daily volatility (0.00).
CPMD vs EVOTF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, EVOTF has a market cap of 1.47B. Regarding current trading prices, CPMD is priced at $0.00, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, CPMD's ROE is +0.52%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, CPMD is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs ARSUF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, ARSUF has a market cap of 1.46B. Regarding current trading prices, CPMD is priced at $0.00, while ARSUF trades at $20.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas ARSUF's P/E ratio is 18.05. In terms of profitability, CPMD's ROE is +0.52%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, CPMD is less volatile compared to ARSUF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs SWGHF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, SWGHF has a market cap of 1.33B. Regarding current trading prices, CPMD is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas SWGHF's P/E ratio is 15.78. In terms of profitability, CPMD's ROE is +0.52%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, CPMD and SWGHF have similar daily volatility (0.00).
CPMD vs GTBIF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, GTBIF has a market cap of 1.30B. Regarding current trading prices, CPMD is priced at $0.00, while GTBIF trades at $5.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas GTBIF's P/E ratio is 26.08. In terms of profitability, CPMD's ROE is +0.52%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, CPMD is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs GNMLF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, GNMLF has a market cap of 1.09B. Regarding current trading prices, CPMD is priced at $0.00, while GNMLF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas GNMLF's P/E ratio is 9.91. In terms of profitability, CPMD's ROE is +0.52%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, CPMD and GNMLF have similar daily volatility (0.00).
CPMD vs KKPCF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, KKPCF has a market cap of 1.03B. Regarding current trading prices, CPMD is priced at $0.00, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas KKPCF's P/E ratio is 10.76. In terms of profitability, CPMD's ROE is +0.52%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, CPMD is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs KSPHF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, KSPHF has a market cap of 994.32M. Regarding current trading prices, CPMD is priced at $0.00, while KSPHF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas KSPHF's P/E ratio is 12.29. In terms of profitability, CPMD's ROE is +0.52%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, CPMD is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs CASBF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, CASBF has a market cap of 970.12M. Regarding current trading prices, CPMD is priced at $0.00, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas CASBF's P/E ratio is -15.24. In terms of profitability, CPMD's ROE is +0.52%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, CPMD is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs SHPHF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, SHPHF has a market cap of 924.41M. Regarding current trading prices, CPMD is priced at $0.00, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, CPMD's ROE is +0.52%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, CPMD is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs BIOGY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, BIOGY has a market cap of 905.20M. Regarding current trading prices, CPMD is priced at $0.00, while BIOGY trades at $9.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas BIOGY's P/E ratio is 29.03. In terms of profitability, CPMD's ROE is +0.52%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, CPMD is less volatile compared to BIOGY. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs LVTTF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, LVTTF has a market cap of 885.32M. Regarding current trading prices, CPMD is priced at $0.00, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, CPMD's ROE is +0.52%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, CPMD is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs EVRRF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, EVRRF has a market cap of 881.50M. Regarding current trading prices, CPMD is priced at $0.00, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, CPMD's ROE is +0.52%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, CPMD and EVRRF have similar daily volatility (0.00).
CPMD vs NRXCF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, NRXCF has a market cap of 836.42M. Regarding current trading prices, CPMD is priced at $0.00, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, CPMD's ROE is +0.52%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, CPMD and NRXCF have similar daily volatility (0.00).
CPMD vs TWAPF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, TWAPF has a market cap of 828.49M. Regarding current trading prices, CPMD is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas TWAPF's P/E ratio is 6.33. In terms of profitability, CPMD's ROE is +0.52%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, CPMD and TWAPF have similar daily volatility (0.00).
CPMD vs CSWYF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, CSWYF has a market cap of 815.83M. Regarding current trading prices, CPMD is priced at $0.00, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, CPMD's ROE is +0.52%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, CPMD is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs TCNNF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, TCNNF has a market cap of 802.53M. Regarding current trading prices, CPMD is priced at $0.00, while TCNNF trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas TCNNF's P/E ratio is -5.32. In terms of profitability, CPMD's ROE is +0.52%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, CPMD is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs TRXPF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, TRXPF has a market cap of 690.69M. Regarding current trading prices, CPMD is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, CPMD's ROE is +0.52%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, CPMD and TRXPF have similar daily volatility (0.00).
CPMD vs SWDCF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, SWDCF has a market cap of 679.32M. Regarding current trading prices, CPMD is priced at $0.00, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, CPMD's ROE is +0.52%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, CPMD is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs NIKA Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, NIKA has a market cap of 672.85M. Regarding current trading prices, CPMD is priced at $0.00, while NIKA trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas NIKA's P/E ratio is N/A. In terms of profitability, CPMD's ROE is +0.52%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, CPMD is less volatile compared to NIKA. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs CURLF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, CURLF has a market cap of 651.60M. Regarding current trading prices, CPMD is priced at $0.00, while CURLF trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas CURLF's P/E ratio is -2.61. In terms of profitability, CPMD's ROE is +0.52%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, CPMD is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs TRSSF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, TRSSF has a market cap of 601.91M. Regarding current trading prices, CPMD is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, CPMD's ROE is +0.52%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, CPMD is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs ELTP Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, ELTP has a market cap of 566.40M. Regarding current trading prices, CPMD is priced at $0.00, while ELTP trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas ELTP's P/E ratio is -26.51. In terms of profitability, CPMD's ROE is +0.52%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, CPMD is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs SGFEF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, SGFEF has a market cap of 523.00M. Regarding current trading prices, CPMD is priced at $0.00, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas SGFEF's P/E ratio is 23.19. In terms of profitability, CPMD's ROE is +0.52%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, CPMD is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs CCHWF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, CCHWF has a market cap of 521.35M. Regarding current trading prices, CPMD is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, CPMD's ROE is +0.52%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, CPMD is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs AIHLF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, AIHLF has a market cap of 507.80M. Regarding current trading prices, CPMD is priced at $0.00, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, CPMD's ROE is +0.52%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, CPMD is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs BOIRF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, BOIRF has a market cap of 494.82M. Regarding current trading prices, CPMD is priced at $0.00, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, CPMD's ROE is +0.52%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, CPMD is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs PEXXF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, PEXXF has a market cap of 463.12M. Regarding current trading prices, CPMD is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, CPMD's ROE is +0.52%, compared to PEXXF's ROE of N/A. Regarding short-term risk, CPMD and PEXXF have similar daily volatility (0.00).
CPMD vs MITPF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, MITPF has a market cap of 451.63M. Regarding current trading prices, CPMD is priced at $0.00, while MITPF trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas MITPF's P/E ratio is -3.05. In terms of profitability, CPMD's ROE is +0.52%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, CPMD and MITPF have similar daily volatility (0.00).
CPMD vs CNGGF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, CNGGF has a market cap of 419.23M. Regarding current trading prices, CPMD is priced at $0.00, while CNGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas CNGGF's P/E ratio is -0.10. In terms of profitability, CPMD's ROE is +0.52%, compared to CNGGF's ROE of -1.60%. Regarding short-term risk, CPMD is less volatile compared to CNGGF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs KHTRF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, KHTRF has a market cap of 415.55M. Regarding current trading prices, CPMD is priced at $0.00, while KHTRF trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas KHTRF's P/E ratio is 59.59. In terms of profitability, CPMD's ROE is +0.52%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, CPMD is less volatile compared to KHTRF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs AGYTF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, AGYTF has a market cap of 405.15M. Regarding current trading prices, CPMD is priced at $0.00, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, CPMD's ROE is +0.52%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, CPMD is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs GLASF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, GLASF has a market cap of 304.38M. Regarding current trading prices, CPMD is priced at $0.00, while GLASF trades at $5.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas GLASF's P/E ratio is -65.44. In terms of profitability, CPMD's ROE is +0.52%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, CPMD is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs PKBFF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, PKBFF has a market cap of 285.89M. Regarding current trading prices, CPMD is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, CPMD's ROE is +0.52%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, CPMD is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs BHCCF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, BHCCF has a market cap of 271.24M. Regarding current trading prices, CPMD is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, CPMD's ROE is +0.52%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, CPMD is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs VRNOF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, VRNOF has a market cap of 248.06M. Regarding current trading prices, CPMD is priced at $0.00, while VRNOF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas VRNOF's P/E ratio is -0.69. In terms of profitability, CPMD's ROE is +0.52%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, CPMD is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs CPHRF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, CPHRF has a market cap of 233.09M. Regarding current trading prices, CPMD is priced at $0.00, while CPHRF trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas CPHRF's P/E ratio is 25.28. In terms of profitability, CPMD's ROE is +0.52%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, CPMD is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs CRLBF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, CRLBF has a market cap of 224.49M. Regarding current trading prices, CPMD is priced at $0.00, while CRLBF trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas CRLBF's P/E ratio is -3.03. In terms of profitability, CPMD's ROE is +0.52%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, CPMD is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs PLNHF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, PLNHF has a market cap of 202.02M. Regarding current trading prices, CPMD is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, CPMD's ROE is +0.52%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, CPMD is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs HUMDF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, HUMDF has a market cap of 147.55M. Regarding current trading prices, CPMD is priced at $0.00, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, CPMD's ROE is +0.52%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, CPMD and HUMDF have similar daily volatility (0.00).
CPMD vs UBQU Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, UBQU has a market cap of 145.41M. Regarding current trading prices, CPMD is priced at $0.00, while UBQU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas UBQU's P/E ratio is N/A. In terms of profitability, CPMD's ROE is +0.52%, compared to UBQU's ROE of -0.38%. Regarding short-term risk, CPMD and UBQU have similar daily volatility (0.00).
CPMD vs COPHF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, COPHF has a market cap of 131.72M. Regarding current trading prices, CPMD is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas COPHF's P/E ratio is -0.02. In terms of profitability, CPMD's ROE is +0.52%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, CPMD is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs STMH Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, STMH has a market cap of 124.24M. Regarding current trading prices, CPMD is priced at $0.00, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas STMH's P/E ratio is N/A. In terms of profitability, CPMD's ROE is +0.52%, compared to STMH's ROE of -2.75%. Regarding short-term risk, CPMD is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs PHCUF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, PHCUF has a market cap of 115.12M. Regarding current trading prices, CPMD is priced at $0.00, while PHCUF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas PHCUF's P/E ratio is 432.00. In terms of profitability, CPMD's ROE is +0.52%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, CPMD is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs LPCUF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, LPCUF has a market cap of 110.82M. Regarding current trading prices, CPMD is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, CPMD's ROE is +0.52%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, CPMD and LPCUF have similar daily volatility (0.00).
CPMD vs CNVCF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, CNVCF has a market cap of 109.16M. Regarding current trading prices, CPMD is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, CPMD's ROE is +0.52%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, CPMD and CNVCF have similar daily volatility (0.00).
CPMD vs HLTRF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, HLTRF has a market cap of 102.37M. Regarding current trading prices, CPMD is priced at $0.00, while HLTRF trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas HLTRF's P/E ratio is -5.65. In terms of profitability, CPMD's ROE is +0.52%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, CPMD is less volatile compared to HLTRF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs BIOYF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, BIOYF has a market cap of 97.96M. Regarding current trading prices, CPMD is priced at $0.00, while BIOYF trades at $8.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas BIOYF's P/E ratio is 17.79. In terms of profitability, CPMD's ROE is +0.52%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, CPMD is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs ABSCF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, ABSCF has a market cap of 92.53M. Regarding current trading prices, CPMD is priced at $0.00, while ABSCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas ABSCF's P/E ratio is -9.41. In terms of profitability, CPMD's ROE is +0.52%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, CPMD is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs GRUSF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, GRUSF has a market cap of 92.44M. Regarding current trading prices, CPMD is priced at $0.00, while GRUSF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas GRUSF's P/E ratio is -7.46. In terms of profitability, CPMD's ROE is +0.52%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, CPMD is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs GBLP Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, GBLP has a market cap of 83.54M. Regarding current trading prices, CPMD is priced at $0.00, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas GBLP's P/E ratio is -0.67. In terms of profitability, CPMD's ROE is +0.52%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, CPMD is less volatile compared to GBLP. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs LOVFF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, LOVFF has a market cap of 83.33M. Regarding current trading prices, CPMD is priced at $0.00, while LOVFF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas LOVFF's P/E ratio is 9.11. In terms of profitability, CPMD's ROE is +0.52%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, CPMD and LOVFF have similar daily volatility (0.00).
CPMD vs LRDSF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, LRDSF has a market cap of 83.32M. Regarding current trading prices, CPMD is priced at $0.00, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, CPMD's ROE is +0.52%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, CPMD is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs CBWTF Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, CBWTF has a market cap of 80.75M. Regarding current trading prices, CPMD is priced at $0.00, while CBWTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas CBWTF's P/E ratio is -6.15. In terms of profitability, CPMD's ROE is +0.52%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, CPMD is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs PLNH Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, PLNH has a market cap of 79.06M. Regarding current trading prices, CPMD is priced at $0.00, while PLNH trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas PLNH's P/E ratio is -1.74. In terms of profitability, CPMD's ROE is +0.52%, compared to PLNH's ROE of -0.32%. Regarding short-term risk, CPMD is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for CPMD.
CPMD vs EOFBY Comparison
CPMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPMD stands at 3.25M. In comparison, EOFBY has a market cap of 73.67M. Regarding current trading prices, CPMD is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPMD currently has a P/E ratio of 0.49, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, CPMD's ROE is +0.52%, compared to EOFBY's ROE of N/A. Regarding short-term risk, CPMD and EOFBY have similar daily volatility (0.00).